Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial

Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP). Is obesity associated with an increased incidence of VAP? This study was a post hoc anal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chest 2021-06, Vol.159 (6), p.2309-2317
Hauptverfasser: Nseir, Saad, Le Gouge, Amélie, Pouly, Olivier, Lascarrou, Jean-Baptiste, Lacherade, Jean-Claude, Mira, Jean-Paul, Mercier, Emmanuelle, Declercq, Pierre-Louis, Sirodot, Michel, Piton, Gaël, Tinturier, François, Coupez, Elisabeth, Gaudry, Stéphane, Djibré, Michel, Thevenin, Didier, Balduyck, Malika, Reignier, Jean
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2317
container_issue 6
container_start_page 2309
container_title Chest
container_volume 159
creator Nseir, Saad
Le Gouge, Amélie
Pouly, Olivier
Lascarrou, Jean-Baptiste
Lacherade, Jean-Claude
Mira, Jean-Paul
Mercier, Emmanuelle
Declercq, Pierre-Louis
Sirodot, Michel
Piton, Gaël
Tinturier, François
Coupez, Elisabeth
Gaudry, Stéphane
Djibré, Michel
Thevenin, Didier
Balduyck, Malika
Reignier, Jean
description Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP). Is obesity associated with an increased incidence of VAP? This study was a post hoc analysis of the Impact of Early Enteral vs Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines (NUTRIREA2) open-label, randomized controlled trial performed in 44 French ICUs. Adults receiving invasive mechanical ventilation and vasopressor support for shock and parenteral nutrition or enteral nutrition were included. Obesity was defined as BMI ≥ 30 kg/m at ICU admission. VAP diagnosis was adjudicated by an independent blinded committee, based on all available clinical, radiologic, and microbiologic data. Only first VAP episodes were taken into account. Incidence of VAP was analyzed by using the Fine and Gray model, with extubation and death as competing risks. A total of 699 (30%) of the 2,325 included patients had obesity; 224 first VAP episodes were diagnosed (60 and 164 in obese and nonobese groups, respectively). The incidence of VAP at day 28 was 8.6% vs 10.1% in the two groups (hazard ratio, 0.85; 95% CI 0.63-1.14; P = .26). After adjustment on sex, McCabe score, age, antiulcer treatment, and Sequential Organ Failure Assessment at randomization, the incidence of VAP remained nonsignificant between obese and nonobese patients (hazard ratio, 0.893; 95% CI, 0.66-1.2; P = .46). Although no significant difference was found in duration of mechanical ventilation and ICU length of stay, 90-day mortality was significantly lower in obese than in nonobese patients (272 of 692 [39.3%] patients vs 718 of 1,605 [44.7%]; P = .02). In a subgroup of patients (n = 123) with available pepsin and alpha-amylase measurements, no significant difference was found in rate of abundant microaspiration of gastric contents, or oropharyngeal secretions between obese and nonobese patients. Our results suggest that obesity has no significant impact on the incidence of VAP.
doi_str_mv 10.1016/j.chest.2021.01.081
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04257556v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2488184658</sourcerecordid><originalsourceid>FETCH-LOGICAL-h245t-9c4cf9d5abf96704446ca79ee35a5c9cd1abceadd59b2fd784724db0fb51a58b3</originalsourceid><addsrcrecordid>eNo90E1r20AQBuAlNMRukl9QKHtsD3L3U9L2poS0DpgkGDtXMdodoTWy1tWuW_zvq-C0MDDM8PAeXkI-cbbgjOffdgvbYUwLwQRfsGlKfkHm3EieSa3kBzJnjItM5kbMyMcYd2y6ucmvyExKnXOl9Zz0a-wh-TDEzh_oHaY_iAN9bjD6dKIwOPqKQ_KTCWNWxRish4SOvgx43IfBw3da0ZcQE10GS6sB-lP0kYaWpg7p03azflw_VIJuRg_9DblsoY94-76vyfbHw-Z-ma2efz7eV6usE0qnzFhlW-M0NK3JC6aUyi0UBlFq0NZYx6GxCM5p04jWFaUqhHINaxvNQZeNvCZfz7kd9PVh9HsYT3UAXy-rVf32Y0roQuv8N5_sl7M9jOHXceqz3vtose9hwHCMtVBlyUuV63Kin9_psdmj-5_8r035F7cKeAo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2488184658</pqid></control><display><type>article</type><title>Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Nseir, Saad ; Le Gouge, Amélie ; Pouly, Olivier ; Lascarrou, Jean-Baptiste ; Lacherade, Jean-Claude ; Mira, Jean-Paul ; Mercier, Emmanuelle ; Declercq, Pierre-Louis ; Sirodot, Michel ; Piton, Gaël ; Tinturier, François ; Coupez, Elisabeth ; Gaudry, Stéphane ; Djibré, Michel ; Thevenin, Didier ; Balduyck, Malika ; Reignier, Jean</creator><creatorcontrib>Nseir, Saad ; Le Gouge, Amélie ; Pouly, Olivier ; Lascarrou, Jean-Baptiste ; Lacherade, Jean-Claude ; Mira, Jean-Paul ; Mercier, Emmanuelle ; Declercq, Pierre-Louis ; Sirodot, Michel ; Piton, Gaël ; Tinturier, François ; Coupez, Elisabeth ; Gaudry, Stéphane ; Djibré, Michel ; Thevenin, Didier ; Balduyck, Malika ; Reignier, Jean ; NUTRIREA2 study group</creatorcontrib><description>Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP). Is obesity associated with an increased incidence of VAP? This study was a post hoc analysis of the Impact of Early Enteral vs Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines (NUTRIREA2) open-label, randomized controlled trial performed in 44 French ICUs. Adults receiving invasive mechanical ventilation and vasopressor support for shock and parenteral nutrition or enteral nutrition were included. Obesity was defined as BMI ≥ 30 kg/m at ICU admission. VAP diagnosis was adjudicated by an independent blinded committee, based on all available clinical, radiologic, and microbiologic data. Only first VAP episodes were taken into account. Incidence of VAP was analyzed by using the Fine and Gray model, with extubation and death as competing risks. A total of 699 (30%) of the 2,325 included patients had obesity; 224 first VAP episodes were diagnosed (60 and 164 in obese and nonobese groups, respectively). The incidence of VAP at day 28 was 8.6% vs 10.1% in the two groups (hazard ratio, 0.85; 95% CI 0.63-1.14; P = .26). After adjustment on sex, McCabe score, age, antiulcer treatment, and Sequential Organ Failure Assessment at randomization, the incidence of VAP remained nonsignificant between obese and nonobese patients (hazard ratio, 0.893; 95% CI, 0.66-1.2; P = .46). Although no significant difference was found in duration of mechanical ventilation and ICU length of stay, 90-day mortality was significantly lower in obese than in nonobese patients (272 of 692 [39.3%] patients vs 718 of 1,605 [44.7%]; P = .02). In a subgroup of patients (n = 123) with available pepsin and alpha-amylase measurements, no significant difference was found in rate of abundant microaspiration of gastric contents, or oropharyngeal secretions between obese and nonobese patients. Our results suggest that obesity has no significant impact on the incidence of VAP.</description><identifier>ISSN: 0012-3692</identifier><identifier>EISSN: 1931-3543</identifier><identifier>DOI: 10.1016/j.chest.2021.01.081</identifier><identifier>PMID: 33561455</identifier><language>eng</language><publisher>United States: American College of Chest Physicians</publisher><subject>Aged ; Body Mass Index ; Chemical Sciences ; Female ; France - epidemiology ; Humans ; Incidence ; Intensive Care Units ; Life Sciences ; Male ; Middle Aged ; Obesity - complications ; or physical chemistry ; Parenteral Nutrition, Total - methods ; Pneumonia, Ventilator-Associated - epidemiology ; Pneumonia, Ventilator-Associated - etiology ; Prevalence ; Prognosis ; Respiration, Artificial - adverse effects ; Risk Factors ; Shock - therapy ; Survival Rate - trends ; Theoretical and</subject><ispartof>Chest, 2021-06, Vol.159 (6), p.2309-2317</ispartof><rights>Copyright © 2021 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0001-6734-5685</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33561455$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.univ-lille.fr/hal-04257556$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Nseir, Saad</creatorcontrib><creatorcontrib>Le Gouge, Amélie</creatorcontrib><creatorcontrib>Pouly, Olivier</creatorcontrib><creatorcontrib>Lascarrou, Jean-Baptiste</creatorcontrib><creatorcontrib>Lacherade, Jean-Claude</creatorcontrib><creatorcontrib>Mira, Jean-Paul</creatorcontrib><creatorcontrib>Mercier, Emmanuelle</creatorcontrib><creatorcontrib>Declercq, Pierre-Louis</creatorcontrib><creatorcontrib>Sirodot, Michel</creatorcontrib><creatorcontrib>Piton, Gaël</creatorcontrib><creatorcontrib>Tinturier, François</creatorcontrib><creatorcontrib>Coupez, Elisabeth</creatorcontrib><creatorcontrib>Gaudry, Stéphane</creatorcontrib><creatorcontrib>Djibré, Michel</creatorcontrib><creatorcontrib>Thevenin, Didier</creatorcontrib><creatorcontrib>Balduyck, Malika</creatorcontrib><creatorcontrib>Reignier, Jean</creatorcontrib><creatorcontrib>NUTRIREA2 study group</creatorcontrib><title>Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial</title><title>Chest</title><addtitle>Chest</addtitle><description>Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP). Is obesity associated with an increased incidence of VAP? This study was a post hoc analysis of the Impact of Early Enteral vs Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines (NUTRIREA2) open-label, randomized controlled trial performed in 44 French ICUs. Adults receiving invasive mechanical ventilation and vasopressor support for shock and parenteral nutrition or enteral nutrition were included. Obesity was defined as BMI ≥ 30 kg/m at ICU admission. VAP diagnosis was adjudicated by an independent blinded committee, based on all available clinical, radiologic, and microbiologic data. Only first VAP episodes were taken into account. Incidence of VAP was analyzed by using the Fine and Gray model, with extubation and death as competing risks. A total of 699 (30%) of the 2,325 included patients had obesity; 224 first VAP episodes were diagnosed (60 and 164 in obese and nonobese groups, respectively). The incidence of VAP at day 28 was 8.6% vs 10.1% in the two groups (hazard ratio, 0.85; 95% CI 0.63-1.14; P = .26). After adjustment on sex, McCabe score, age, antiulcer treatment, and Sequential Organ Failure Assessment at randomization, the incidence of VAP remained nonsignificant between obese and nonobese patients (hazard ratio, 0.893; 95% CI, 0.66-1.2; P = .46). Although no significant difference was found in duration of mechanical ventilation and ICU length of stay, 90-day mortality was significantly lower in obese than in nonobese patients (272 of 692 [39.3%] patients vs 718 of 1,605 [44.7%]; P = .02). In a subgroup of patients (n = 123) with available pepsin and alpha-amylase measurements, no significant difference was found in rate of abundant microaspiration of gastric contents, or oropharyngeal secretions between obese and nonobese patients. Our results suggest that obesity has no significant impact on the incidence of VAP.</description><subject>Aged</subject><subject>Body Mass Index</subject><subject>Chemical Sciences</subject><subject>Female</subject><subject>France - epidemiology</subject><subject>Humans</subject><subject>Incidence</subject><subject>Intensive Care Units</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Obesity - complications</subject><subject>or physical chemistry</subject><subject>Parenteral Nutrition, Total - methods</subject><subject>Pneumonia, Ventilator-Associated - epidemiology</subject><subject>Pneumonia, Ventilator-Associated - etiology</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Respiration, Artificial - adverse effects</subject><subject>Risk Factors</subject><subject>Shock - therapy</subject><subject>Survival Rate - trends</subject><subject>Theoretical and</subject><issn>0012-3692</issn><issn>1931-3543</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90E1r20AQBuAlNMRukl9QKHtsD3L3U9L2poS0DpgkGDtXMdodoTWy1tWuW_zvq-C0MDDM8PAeXkI-cbbgjOffdgvbYUwLwQRfsGlKfkHm3EieSa3kBzJnjItM5kbMyMcYd2y6ucmvyExKnXOl9Zz0a-wh-TDEzh_oHaY_iAN9bjD6dKIwOPqKQ_KTCWNWxRish4SOvgx43IfBw3da0ZcQE10GS6sB-lP0kYaWpg7p03azflw_VIJuRg_9DblsoY94-76vyfbHw-Z-ma2efz7eV6usE0qnzFhlW-M0NK3JC6aUyi0UBlFq0NZYx6GxCM5p04jWFaUqhHINaxvNQZeNvCZfz7kd9PVh9HsYT3UAXy-rVf32Y0roQuv8N5_sl7M9jOHXceqz3vtose9hwHCMtVBlyUuV63Kin9_psdmj-5_8r035F7cKeAo</recordid><startdate>20210601</startdate><enddate>20210601</enddate><creator>Nseir, Saad</creator><creator>Le Gouge, Amélie</creator><creator>Pouly, Olivier</creator><creator>Lascarrou, Jean-Baptiste</creator><creator>Lacherade, Jean-Claude</creator><creator>Mira, Jean-Paul</creator><creator>Mercier, Emmanuelle</creator><creator>Declercq, Pierre-Louis</creator><creator>Sirodot, Michel</creator><creator>Piton, Gaël</creator><creator>Tinturier, François</creator><creator>Coupez, Elisabeth</creator><creator>Gaudry, Stéphane</creator><creator>Djibré, Michel</creator><creator>Thevenin, Didier</creator><creator>Balduyck, Malika</creator><creator>Reignier, Jean</creator><general>American College of Chest Physicians</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-6734-5685</orcidid></search><sort><creationdate>20210601</creationdate><title>Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial</title><author>Nseir, Saad ; Le Gouge, Amélie ; Pouly, Olivier ; Lascarrou, Jean-Baptiste ; Lacherade, Jean-Claude ; Mira, Jean-Paul ; Mercier, Emmanuelle ; Declercq, Pierre-Louis ; Sirodot, Michel ; Piton, Gaël ; Tinturier, François ; Coupez, Elisabeth ; Gaudry, Stéphane ; Djibré, Michel ; Thevenin, Didier ; Balduyck, Malika ; Reignier, Jean</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h245t-9c4cf9d5abf96704446ca79ee35a5c9cd1abceadd59b2fd784724db0fb51a58b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Body Mass Index</topic><topic>Chemical Sciences</topic><topic>Female</topic><topic>France - epidemiology</topic><topic>Humans</topic><topic>Incidence</topic><topic>Intensive Care Units</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Obesity - complications</topic><topic>or physical chemistry</topic><topic>Parenteral Nutrition, Total - methods</topic><topic>Pneumonia, Ventilator-Associated - epidemiology</topic><topic>Pneumonia, Ventilator-Associated - etiology</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Respiration, Artificial - adverse effects</topic><topic>Risk Factors</topic><topic>Shock - therapy</topic><topic>Survival Rate - trends</topic><topic>Theoretical and</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nseir, Saad</creatorcontrib><creatorcontrib>Le Gouge, Amélie</creatorcontrib><creatorcontrib>Pouly, Olivier</creatorcontrib><creatorcontrib>Lascarrou, Jean-Baptiste</creatorcontrib><creatorcontrib>Lacherade, Jean-Claude</creatorcontrib><creatorcontrib>Mira, Jean-Paul</creatorcontrib><creatorcontrib>Mercier, Emmanuelle</creatorcontrib><creatorcontrib>Declercq, Pierre-Louis</creatorcontrib><creatorcontrib>Sirodot, Michel</creatorcontrib><creatorcontrib>Piton, Gaël</creatorcontrib><creatorcontrib>Tinturier, François</creatorcontrib><creatorcontrib>Coupez, Elisabeth</creatorcontrib><creatorcontrib>Gaudry, Stéphane</creatorcontrib><creatorcontrib>Djibré, Michel</creatorcontrib><creatorcontrib>Thevenin, Didier</creatorcontrib><creatorcontrib>Balduyck, Malika</creatorcontrib><creatorcontrib>Reignier, Jean</creatorcontrib><creatorcontrib>NUTRIREA2 study group</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Chest</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nseir, Saad</au><au>Le Gouge, Amélie</au><au>Pouly, Olivier</au><au>Lascarrou, Jean-Baptiste</au><au>Lacherade, Jean-Claude</au><au>Mira, Jean-Paul</au><au>Mercier, Emmanuelle</au><au>Declercq, Pierre-Louis</au><au>Sirodot, Michel</au><au>Piton, Gaël</au><au>Tinturier, François</au><au>Coupez, Elisabeth</au><au>Gaudry, Stéphane</au><au>Djibré, Michel</au><au>Thevenin, Didier</au><au>Balduyck, Malika</au><au>Reignier, Jean</au><aucorp>NUTRIREA2 study group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial</atitle><jtitle>Chest</jtitle><addtitle>Chest</addtitle><date>2021-06-01</date><risdate>2021</risdate><volume>159</volume><issue>6</issue><spage>2309</spage><epage>2317</epage><pages>2309-2317</pages><issn>0012-3692</issn><eissn>1931-3543</eissn><abstract>Patients with obesity are at higher risk for community-acquired and nosocomial infections. However, no study has specifically evaluated the relationship between obesity and ventilator-associated pneumonia (VAP). Is obesity associated with an increased incidence of VAP? This study was a post hoc analysis of the Impact of Early Enteral vs Parenteral Nutrition on Mortality in Patients Requiring Mechanical Ventilation and Catecholamines (NUTRIREA2) open-label, randomized controlled trial performed in 44 French ICUs. Adults receiving invasive mechanical ventilation and vasopressor support for shock and parenteral nutrition or enteral nutrition were included. Obesity was defined as BMI ≥ 30 kg/m at ICU admission. VAP diagnosis was adjudicated by an independent blinded committee, based on all available clinical, radiologic, and microbiologic data. Only first VAP episodes were taken into account. Incidence of VAP was analyzed by using the Fine and Gray model, with extubation and death as competing risks. A total of 699 (30%) of the 2,325 included patients had obesity; 224 first VAP episodes were diagnosed (60 and 164 in obese and nonobese groups, respectively). The incidence of VAP at day 28 was 8.6% vs 10.1% in the two groups (hazard ratio, 0.85; 95% CI 0.63-1.14; P = .26). After adjustment on sex, McCabe score, age, antiulcer treatment, and Sequential Organ Failure Assessment at randomization, the incidence of VAP remained nonsignificant between obese and nonobese patients (hazard ratio, 0.893; 95% CI, 0.66-1.2; P = .46). Although no significant difference was found in duration of mechanical ventilation and ICU length of stay, 90-day mortality was significantly lower in obese than in nonobese patients (272 of 692 [39.3%] patients vs 718 of 1,605 [44.7%]; P = .02). In a subgroup of patients (n = 123) with available pepsin and alpha-amylase measurements, no significant difference was found in rate of abundant microaspiration of gastric contents, or oropharyngeal secretions between obese and nonobese patients. Our results suggest that obesity has no significant impact on the incidence of VAP.</abstract><cop>United States</cop><pub>American College of Chest Physicians</pub><pmid>33561455</pmid><doi>10.1016/j.chest.2021.01.081</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6734-5685</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-3692
ispartof Chest, 2021-06, Vol.159 (6), p.2309-2317
issn 0012-3692
1931-3543
language eng
recordid cdi_hal_primary_oai_HAL_hal_04257556v1
source MEDLINE; Alma/SFX Local Collection
subjects Aged
Body Mass Index
Chemical Sciences
Female
France - epidemiology
Humans
Incidence
Intensive Care Units
Life Sciences
Male
Middle Aged
Obesity - complications
or physical chemistry
Parenteral Nutrition, Total - methods
Pneumonia, Ventilator-Associated - epidemiology
Pneumonia, Ventilator-Associated - etiology
Prevalence
Prognosis
Respiration, Artificial - adverse effects
Risk Factors
Shock - therapy
Survival Rate - trends
Theoretical and
title Relationship Between Obesity and Ventilator-Associated Pneumonia: A Post Hoc Analysis of the NUTRIREA2 Trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T12%3A12%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Relationship%20Between%20Obesity%20and%20Ventilator-Associated%20Pneumonia:%20A%20Post%20Hoc%20Analysis%20of%20the%20NUTRIREA2%20Trial&rft.jtitle=Chest&rft.au=Nseir,%20Saad&rft.aucorp=NUTRIREA2%20study%20group&rft.date=2021-06-01&rft.volume=159&rft.issue=6&rft.spage=2309&rft.epage=2317&rft.pages=2309-2317&rft.issn=0012-3692&rft.eissn=1931-3543&rft_id=info:doi/10.1016/j.chest.2021.01.081&rft_dat=%3Cproquest_hal_p%3E2488184658%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2488184658&rft_id=info:pmid/33561455&rfr_iscdi=true